未登录

C

Cara C. Wilson

University of Colorado System

H指数:38

被引数:3,955

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endogenous retroelement expression in the gut microenvironment of people living with HIV-1

IF10.8

2024-05-010

OAAI

Altered Immunoglobulin Repertoire and Decreased IgA Somatic Hypermutation in the Gut during Chronic HIV-1 Infection

JOURNAL OF VIROLOGY

IF3.8

2022-09-144

OAAI

Granzyme B+ CD4 T cells accumulate in the colon during chronic HIV-1 infection

IF11

2022-03-085

OAAI

Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis

IF4.9

2020-10-1623

OAAI

High-fat diet exacerbates SIV pathogenesis and accelerates disease progression

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2019-11-1132

OA

A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis

慢性HIV-1感染期间肠道中的I型干扰素反应与免疫发病机制有关

IF3.1

2018-07-3117

OAAI

The transcriptome of HIV-1 infected intestinal CD4+T cells exposed to enteric bacteria

IF4.9

2017-02-2733

OAAI

Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation

HIV感染中结肠产丁酸细菌的丰度低与微生物易位和免疫激活有关

IF3.1

2017-02-20128

OAAI

The gut microbiome and HIV-1 pathogenesis: a two-way street

IF3.1

2016-11-28138

OAAI

Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo

JOURNAL OF VIROLOGY

IF3.8

2016-07-01110

OAAI

Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques

IF4.9

2016-01-1439

OAAI

Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection

MUCOSAL IMMUNOLOGY

IF7.6

2016-01-01183

OAAI

Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms

IF4.9

2015-11-0383

OAAI

Using the Pathogenic and Nonpathogenic Nonhuman Primate Model for Studying Non-AIDS Comorbidities

CURRENT HIV/AIDS REPORTS

IF4.4

2015-01-2222

OAAI

Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy - ACTG A5286

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2014-09-1166

OAAI

Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2014-05-2673

OA

Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2014-05-1693

OA

Increased Escherichia coli-Induced Interleukin-23 Production by CD16+ Monocytes Correlates with Systemic Immune Activation in Untreated HIV-1-Infected Individuals

JOURNAL OF VIROLOGY

IF3.8

2013-12-1513

OAAI

HIV-1 Infection of Human Intestinal Lamina Propria CD4+ T Cells In Vitro Is Enhanced by Exposure to Commensal Escherichia coli

JOURNAL OF IMMUNOLOGY

IF3.4

2012-07-1559

OAAI

CD28-Negative CD4+ and CD8+ T Cells in Antiretroviral Therapy-Naive HIV-Infected Adults Enrolled in Adult Clinical Trials Group Studies

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2012-03-2337

OAAI